News & Updates from C17 Council-Childrens Cancer & Blood Disorders. Their goal is to improve outcomes and quality of life for children and adolescents with cancer and serious blood disorders in Canada.
Job Summary: To coordinate data collection and management for the local component of the national pediatric oncology surveillance program (CYP-C: Cancer in Young People in Canada). The project is supported by a grant from the Federal Public Health Agency of Canada. Data for children diagnosed in British Columbia prior to the start of the project will be obtained from medical records and entered into a national database. The RT3 works with physicians and staff in the Data Management office and Oncology clinic. The RT3’s office is located in the Shaughnessy Building.
THE CANCER RESEARCH SOCIETY IS PLEASED TO ANNOUNCE A NEW FUNDING PROGRAM
Translational Research Partnership Program
In addition to its regular funding programs, the Cancer Research Society is pleased to support high-impact translational projects throughout Canada. Our aim is to work in collaboration with partners to co-fund bold research projects in order to accelerate the development of new and innovative treatments or medical devices for the benefit of patients.
Programme de partenariat de recherche translationnelle
Programme de partenariat de recherche translationnelle
En plus de ses programmes de financement réguliers, la Société de recherche sur le cancer a plaisir d’appuyer des projets de recherche translationnelle à haut impact au Canada. L’objectif est de travailler en collaboration avec des partenaires pour cofinancer des projets de recherche audacieux afin d’accélérer le développement de nouvelles approches thérapeutiques ou de technologies médicales innovantes au bénéfice des patients.
The following is from Vickie Buenger, President of the Coalition Against Childhood Cancer www.cac2.org and is being shared with the membership of CAC2.
This Friday is International Childhood Cancer Day. To help your planning, I am forwarding the information and images that Jess and Neal (as Awareness and Advocacy leads) have pulled together to support a coordinated campaign around this opportunity and make it easier for CAC2 members to participate if they choose to. CAC2 members will receive the information contained below on Wednesday, and they will receive a second email early on Friday morning. If you already have your own plans, great. This is just to simplify the process a bit.
The Adolescent and Young Adult Survivorship Symposium: A New Vision aims to engage local, national and international experts and trainees to build a framework for the delivery of survivorship care for survivors of young adult cancer.
Dr. Lois Travis, MD, ScD Director of the Cancer Survivorship Research Program Melvin and Bren Simon Cancer Centre, Indiana University
Day 1: How Can a Program Can Help Young Adults with Cancer?
Learn about and develop skills in identifying, assessing and intervening on the unique needs of young adults with cancer. Participants will gain an understanding of effective models of care for addressing AYA-specific issues.
Day 2: Surveillance and Screening for Survivors of Adolescent and Young Adult Cancer
Participants will have increased awareness and knowledge of common treatment-related late effects in younger adult cancer survivors and evidence-based interventions for managing them.
Please forward this message to all postdoctoral fellows interested in pursuing a career in cancer research in Canada.
The Cancer Research Society is pleased to announce the launch of its 2019 Scholarships for the Next Generation of Scientists competition, an initiative aiming at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal.
Deadlines for submitting an application: April 26, 2019, 11:59 pm (EST).
Part 1: Postdoctoral Salary Award – 1 year * – $50,000 One year postdoctoral salary award for a candidate finishing his/her fellowship. The candidate must have completed at least two years of postdoctoral training at the time he/she accepts the salary award. * Possibility of extending Part 1 of this award for a maximum period of 6 months.
Part 2: Operating Grant – 2 years – $120,000 ($60,000/year) Operating grant award once the candidate has obtained a faculty position at a recognized Canadian institution.
You have two options for submitting your application.
Sending your application and accompanying documents using the button provided on our website. The deadline for submitting your electronic files is April 26 2019, 11:59 pm (EST).
Saving on two (2) CDs or two (2) USB keys and sending it by mail or courier, as per the instructions on our website. The deadline for mailing your application is April 26, 2019. Applications must be postmarked on or before this date.
For additional information on the competition, please visit our website.
For all questions, please contact Lucille Beaudet or Irina Navarrete at firstname.lastname@example.org or, toll free, 1 888-766-2262.
NCI is now accepting applications for the funding opportunity “Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors” (RFA-CA-19-033**).
The full request for applications (RFA) is available here.
This RFA aims to develop and test interventions that prevent, mitigate, or manage adverse outcomes in pediatric and/or AYA cancer survivors and/or evaluate models of care that strengthen coordination, continuity, and quality, or that reduce access barriers to needed services including follow-up care, and that improve outcomes across the survivor’s lifespan.
This RFA is associated with the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act of 2018 that is intended to maximize and accelerate discovery, development, and availability of promising childhood cancer treatments. National Brain Tumor Society (NBTS) is proud to be one of a handful of pediatric cancer organizations who convened to identify, coordinate, and prioritize the needs of the pediatric cancer population which led to the STAR Act.
Applications are encouraged that address any of the following areas relevant to pediatric and AYA cancer survivors, as outlined in the STAR Act:
Outcomes and/or Barriers to follow-up care, including within minority or other medically underserved populations and with respect to health disparities
The impact of relevant factors, which may include familial, socioeconomic, and other environmental factors, on treatment outcomes and survivorship
The development of indicators used for long-term follow-up and analysis of the late effects of cancer treatment
The identification of risk factors associated with late effects of treatment; predictors of adverse neurocognitive and psychosocial outcomes; and the molecular basis of long-term and late complications
The development of targeted interventions to reduce the burden of morbidity borne by cancer survivors to protect such cancer survivors from the late effects of cancer or its treatment
Working with our brain tumor advocates, NBTS coordinated hundreds of meetings with congressional offices to share the importance of this bill and encourage Member support. Because of the devoted efforts from volunteer advocates, and the collaboration across many pediatric cancer organizations, the STAR Act became law in record time and will have a lasting impact on the pediatric brain tumor population.
Thank you for your ongoing dedication to the needs of brain tumor patients and their families.
C17 is pleased to announce a call for applications for the The 100% Fund Grant Competition targeting INFANT LEUKEMIA.
The purpose of The 100% Fund Grant Competition is to target directly pediatric cancers that are rare and hard to treat—cancers that have not responded to available therapies. Applications addressing infant leukemia will be considered for the 2019 100% Fund Grant Competition.
Projects can range from discovery to clinical trials, but must be focused towards a treatment intervention. The goal is to fund research with the potential to deliver improved treatment and increased survival rates.
Please note that this is a reissue of the call for application for research in infant leukemia. The 100% Fund LOI for infant leukemia is now replaced by a Letter of Registration (LOR) that is due by 1 Feb 2019 (4pm MT). The registration form can be downloaded from C17.ca and asks for brief administrative details, draft project title, research areas and a very brief/general project description. The 100% Fund Grants targeting infant leukemia will be reviewed in conjunction with the ongoing 2018/2019 Round 22 of grants due 13 April 2019.
The submission deadline for C17 LORs is February 01, 2019 at 4 PM MT.
This year, ICCD is focusing on reducing cancer and treatment related pain. In 2011, a study found that 65.6% of countries worldwide offered no palliative care services for children. Help us fight for #NoMorePain.
What is ICCD? International Childhood Cancer Day is a global collaborative campaign to raise awareness and promote an increased appreciation and deeper understanding of the challenges faced by children and adolescents with cancer, the survivors and their families. ICCD spotlights the need for more equitable access to treatment and care for all children with cancer, everywhere.
DOWNLOAD: Please feel free to download the ICCD 2019 Toolkit HERE. You can find the artwork for the new ICCD logo, as well as custom posters, graphs and social media tools, specifically created for member organizations to use in the event planning process to raise awareness about the need to eliminate pain and suffering of children with cancer.
EDUCATE: The CCI Board of Trustees applaud the 2018 release of the WHO’s palliative care guide entitled, Integrating Palliative Care and Symptom Relief into Paediatrics: A WHO guide for healthcare planners, implementers and managers. CCI encourages all members to share this valuable document with those in your countries who provide the planning, implementing, managing or assuring access to quality of palliative care for children. Download HERE.
ADD FRAME TO SOCIAL MEDIA: Raise awareness about the need to reduce cancer and treatment related pain by participating in our #NoMorePain Campaign! Use our Facebook Frames found in the Toolkit to raise awareness of children and their families in your country. Please use the hashtag #NoMorePain as well as #ICCD2019 when posting on social media.
The goal of the C17 Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals. This is an annual scholarship offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation.
Eligibility: Non-MD Pediatric Oncology/Hematology/BMT health care professionals working in Canada.
Application deadlines: May 1st, August 1st, November 1st, February 1st annually
Individuals applying must be involved in a C17 Oncology, Hematology or BMT program and is not a physician resident or university student (can be nursing, social work, child life, physiotherapy, occupational therapy, etc).
A maximum of $1000.00 Canadian will be awarded to each applicant.
Applicants can re-apply for funding each year but priority will be given to those who have not received funding previously. This grant is not retroactive.